Candriam SCA’s Redhill Biopharma RDHL Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q2 | – | Sell |
-71
| Closed | -$180K | – | 817 |
|
2022
Q1 | $180K | Hold |
71
| – | – | ﹤0.01% | 777 |
|
2021
Q4 | $184K | Sell |
71
-12
| -14% | -$31.1K | ﹤0.01% | 787 |
|
2021
Q3 | $378K | Hold |
83
| – | – | ﹤0.01% | 794 |
|
2021
Q2 | $568K | Hold |
83
| – | – | ﹤0.01% | 787 |
|
2021
Q1 | $637K | Hold |
83
| – | – | 0.01% | 693 |
|
2020
Q4 | $663K | Hold |
83
| – | – | 0.01% | 705 |
|
2020
Q3 | $843K | Hold |
83
| – | – | 0.01% | 636 |
|
2020
Q2 | $553K | Buy |
83
+12
| +17% | +$80K | 0.01% | 693 |
|
2020
Q1 | $424K | Hold |
71
| – | – | ﹤0.01% | 723 |
|
2019
Q4 | $433K | Hold |
71
| – | – | ﹤0.01% | 741 |
|
2019
Q3 | $502K | Hold |
71
| – | – | 0.01% | 686 |
|
2019
Q2 | $461K | Hold |
71
| – | – | 0.01% | 742 |
|
2019
Q1 | $592K | Hold |
71
| – | – | 0.01% | 694 |
|
2018
Q4 | $395K | Hold |
71
| – | – | 0.01% | 718 |
|
2018
Q3 | $629K | Hold |
71
| – | – | 0.01% | 684 |
|
2018
Q2 | $608K | Hold |
71
| – | – | 0.01% | 675 |
|
2018
Q1 | $367K | Hold |
71
| – | – | 0.01% | 709 |
|
2017
Q4 | $368K | Hold |
71
| – | – | 0.01% | 706 |
|
2017
Q3 | $770K | Hold |
71
| – | – | 0.01% | 608 |
|
2017
Q2 | $619K | Hold |
71
| – | – | 0.01% | 639 |
|
2017
Q1 | $683K | Hold |
71
| – | – | 0.01% | 615 |
|
2016
Q4 | $745K | Hold |
71
| – | – | 0.02% | 560 |
|
2016
Q3 | $992K | Hold |
71
| – | – | 0.02% | 498 |
|
2016
Q2 | $778K | Hold |
71
| – | – | 0.02% | 485 |
|
2016
Q1 | $868K | Hold |
71
| – | – | 0.02% | 454 |
|
2015
Q4 | $914K | Hold |
71
| – | – | 0.02% | 396 |
|
2015
Q3 | $920K | Hold |
71
| – | – | 0.02% | 445 |
|
2015
Q2 | $1.26M | Hold |
71
| – | – | 0.03% | 416 |
|
2015
Q1 | $1.04M | Hold |
71
| – | – | 0.02% | 450 |
|
2014
Q4 | $945K | Buy |
+71
| New | +$945K | 0.02% | 444 |
|